India has taken a significant step towards regulating artificial intelligence (AI) in healthcare with the introduction of two initiatives: the Secure AI for Health Initiative (SAHI) and the Benchmarking Open Data Platform for Health AI (BODH). Announced by Union Health Minister JP Nadda during the AI Impact Summit 2026, these initiatives aim to ensure responsible AI adoption while balancing innovation with patient safety.
Overview of SAHI and BODH
The SAHI and BODH initiatives are designed as a national framework for the development, validation, and implementation of AI technologies across various sectors, including hospitals, public health systems, pharmaceutical research, and digital health platforms. Developed in collaboration with the Indian Institute of Technology (IIT) Kanpur and the National Health Authority, BODH will facilitate the systematic evaluation of AI models utilizing diverse, anonymized real-world health datasets.
During the summit, Nadda emphasized the importance of interoperability and consent-based health data frameworks. He remarked, “Interoperable systems have been enabled across platforms, and large-scale, consent-based health data frameworks are being developed to empower citizens while ensuring data privacy and security.” The integration of these frameworks indicates India’s commitment to fostering innovation within a secure environment.
India’s Evolving Digital Health Landscape
India’s government has been laying the groundwork for a digital transformation since the launch of the Digital India programme in 2015. This initiative aimed to create a digitally empowered society and knowledge economy. Following this, the National Health Policy was introduced in 2017 to establish a comprehensive digital health ecosystem. In 2020, the government rolled out the Ayushman Bharat Digital Mission (ABDM), aimed at strengthening the country’s digital public health architecture.
The introduction of SAHI and BODH aligns with these earlier efforts, indicating a concerted push towards enhancing healthcare through technology. Both initiatives are expected to boost the development of AI tools while ensuring that patient data privacy remains paramount.
AI’s integration into healthcare is already making a notable impact. The technology is widely employed in diagnostic imaging, administrative automation, and patient monitoring, allowing healthcare providers to focus more on patient care rather than administrative burdens. According to officials, BODH will assess AI systems for accuracy, bias, reliability, and adaptability, further safeguarding patient data privacy.
As the government implements stricter data privacy regulations, validation parameters, and accountability systems, the focus on human-centered care is also being renewed. Nadda highlighted the potential of AI in pharmaceutical research and clinical trials, stating that advanced algorithms could shorten drug discovery cycles, enhance trial precision, and reduce costs. This could ultimately lead to more affordable healthcare delivery for the population.
The launch of SAHI and BODH represents a pivotal moment in India’s approach to AI governance in healthcare. By setting these guardrails, the government aims to ensure that AI technologies contribute positively to health outcomes while maintaining trust in digital healthcare solutions. As the world watches, India’s commitment to responsible innovation could serve as a model for other nations navigating the complexities of AI in health.
